Nokia Corporation (ADR) (NYSE:NOK), now part of Microsoft, has been developing 3D Touch technology which is expected to debut on a flagship smartphone coming out later this year. The device, codenamed the ‘Lumia McLaren’, represents Microsoft’s latest efforts in exploring the concept of integrating Kinect-like motion detecting features into Windows Phone. This is a unique aspect other companies have yet to include on a mobile device so far, reports The Verge. Nokia Corporation (ADR) (NYSE:NOK) net profit margin is -9.50% and weekly performance is 1.00%. On last trading day company shares ended up $8.06. Analysts mean target price for the company is $8.10. Nokia Corporation (ADR) (NYSE:NOK) distance from 50-day simple moving average (SMA50) is 7.38%.
Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) a fully integrated specialty biopharmaceutical company, announced that it has partnered withPrasco, LLC (“Prasco”) to introduce an Authorized Generic version of Testim® (testosterone gel). Prasco has product inventory available and has commenced shipping product. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) shares fell -1.18% in last trading session and ended the day on $21.79. Gross Margin is 72.80 % and its return on assets is -6.40%. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) quarterly performance is -25.81%.
eBay Inc. (NASDAQ:EBAY) is planning to shut down its same-day delivery service after two years of its launch, according to Venture Beat. eBay found out no gains from its one-hour delivery service from a select retailers to just about anywhere in San Francisco. The customers need to pay $5 more for this special one-hour delivery service. However, the online retailer had to bear a greater toll as it has to pay couriers their hourly rate regardless of delivery orders. eBay Inc (NASDAQ:EBAY) shares moved down -2.98% in last trading session and was closed at $48.25 , while trading in range of $48.50- $49.73. eBay Inc (NASDAQ:EBAY) year to date (YTD) performance is -12.06%.
On June 7, Shares of Yamana Gold Inc. (USA) (NYSE:AUY) have received a consensus rating of “Buy” from the twenty-one brokerages that are presently covering the company,StockRatingsNetwork.com reports. One analyst has rated the stock with a sell rating, six have assigned a hold rating and eleven have assigned a buy rating to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $11.93. Yamana Gold Inc. (USA) (NYSE:AUY) ended the last trading day at $7.60. Company weekly volatility is calculated as 1.98% and price to cash ratio as 19.77. Yamana Gold Inc. (USA) (NYSE:AUY) showed a positive weekly performance of 2.01%.
GlaxoSmithKline plc and Theravance, Inc. (NASDAQ:THRX) announced positive results from two phase III studies, which showed that patients with chronic obstructive pulmonary disease (COPD) who received the anticholinergic, Incruse™ Ellipta®(umeclidinium (UMEC) 62.5mcg), or umeclidinium 125mcg (an unlicensed dose) in addition to Relvar®/Breo® Ellipta® (fluticasone furoate/vilanterol, “FF/VI”), an inhaled corticosteroid / long-acting beta2-agonist combination, achieved an additional improvement in lung function (FEV1) compared to patients receiving FF/VI plus placebo. Theravance Inc (NASDAQ:THRX) weekly performance is 9.96%. On last trading day company shares ended up $25.40. Analysts mean target price for the company is $33.71. Theravance Inc (NASDAQ:THRX) distance from 50-day simple moving average (SMA50) is 11.94%.
Leave a Reply